Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis
Christopher D. Wiley, Alexis N. Brumwell, Sonnet S. Davis, Julia R. Jackson, Alexis Valdovinos, Cheresa Calhoun, Fatouma Alimirah, Carlos A. Castellanos, Richard Ruan, Ying Wei, Harold A. Chapman, Arvind Ramanathan, Judith Campisi, Claude Jourdan Le Saux
Christopher D. Wiley, Alexis N. Brumwell, Sonnet S. Davis, Julia R. Jackson, Alexis Valdovinos, Cheresa Calhoun, Fatouma Alimirah, Carlos A. Castellanos, Richard Ruan, Ying Wei, Harold A. Chapman, Arvind Ramanathan, Judith Campisi, Claude Jourdan Le Saux
View: Text | PDF
Research Article Cell biology Pulmonology

Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis

  • Text
  • PDF
Abstract

Accumulation of senescent cells is associated with the progression of pulmonary fibrosis, but mechanisms accounting for this linkage are not well understood. To explore this issue, we investigated whether a class of biologically active profibrotic lipids, the leukotrienes (LT), is part of the senescence-associated secretory phenotype. The analysis of conditioned medium (CM), lipid extracts, and gene expression of LT biosynthesis enzymes revealed that senescent cells secreted LT, regardless of the origin of the cells or the modality of senescence induction. The synthesis of LT was biphasic and followed by antifibrotic prostaglandin (PG) secretion. The LT-rich CM of senescent lung fibroblasts (IMR-90) induced profibrotic signaling in naive fibroblasts, which were abrogated by inhibitors of ALOX5, the principal enzyme in LT biosynthesis. The bleomycin-induced expression of genes encoding LT and PG synthases, level of cysteinyl LT in the bronchoalveolar lavage, and overall fibrosis were reduced upon senescent cell removal either in a genetic mouse model or after senolytic treatment. Quantification of ALOX5+ cells in lung explants obtained from idiopathic pulmonary fibrosis (IPF) patients indicated that half of these cells were also senescent (p16Ink4a+). Unlike human fibroblasts from unused donor lungs made senescent by irradiation, senescent IPF fibroblasts secreted LTs but failed to synthesize PGs. This study demonstrates for the first time to our knowledge that senescent cells secrete functional LTs, significantly contributing to the LT pool known to cause or exacerbate IPF.

Authors

Christopher D. Wiley, Alexis N. Brumwell, Sonnet S. Davis, Julia R. Jackson, Alexis Valdovinos, Cheresa Calhoun, Fatouma Alimirah, Carlos A. Castellanos, Richard Ruan, Ying Wei, Harold A. Chapman, Arvind Ramanathan, Judith Campisi, Claude Jourdan Le Saux

×

Figure 7

Temporal changes in eicosanoid biosynthesis reveal pro- and antifibrotic activities of senescent cells.

Options: View larger image (or click on image) Download as PowerPoint
Temporal changes in eicosanoid biosynthesis reveal pro- and antifibrotic...
(A) Isolated CD45+ cells from 14-day bleomycin-injured lungs were treated with DMSO and 10 μM ABT-263 for 48 hours. Analysis of mRNA expression of LT and PG biosynthesis enzymes was performed by qPCR. (B) Analysis by flow cytometry of percent of CD45+ cells isolated from 14-day bleomycin-injured lungs treated ABT-263 or vehicle for 7 days. (C and D) p16Ink4a-3MR mice received a single intratracheal injection of PBS (vehicle control) or bleomycin (Bleo, 1.9U/kg). (C) Level of p16INK4a mRNA levels normalized to tubulin mRNA. (D) Hydroxyproline levels obtained using the right lung lobes of mice, 21 days after bleomycin injury. (E) Lipids were extracted from broncho-alveolar lavage fluid (BALF) collected 21 days after bleomycin injury. BALF lipid content was analyzed for cysteinyl leukotrienes by ELISA. (E) Whole lung tissues were collected 14, 21, and 42 days after PBS or bleomycin intratracheal injection for RNA extraction (7 mice per group) and analyzed by qPCR. (F) mRNA levels of p16INK4a (p16, green line) and collagen (COL1A2, orange line), normalized to tubulin mRNA. (G) mRNA levels of ALOX5 (gray line) and PTGDS (green line) normalized to tubulin mRNA. Statistical analyses were performed using Student’s t test (A), 1-way ANOVA (C, D, and E), or individual 2-tailed unpaired Student’s t test. *P ≤ 0.05; **P ≤ 0.01; ****P ≤ 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts